Systemic Hypersensitivity Reaction to Goserelin Acetate

S G Raj, Raj SG, Karadsheh AJ, Adli J. Karadsheh, A J Karadsheh, R J Guillot, Guillot RJ, Richard J. Guillot, Raj MH, M H Raj, Madhwa H.G. Raj, Kumar P, Prem Kumar, P Kumar
The American journal of the medical sciences · 1996 · vol. 312(4) , pp. 187–190 · doi:10.1097/00000441-199610000-00007 · PMID:8853068 · W2995966470
article OA: closed CC0 ⤵ 1 in-corpus citation
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This report describes a patient experiencing a systemic hypersensitivity reaction, including urticaria and angioedema, following administration of goserelin acetate.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Women suffering from endometriosis are treated with long-acting analogues of gonadotropin-releasing hormone (GnRH). This is a case of hypersensitivity reaction to a goserelin acetate implant that manifested as an anaphylactic reaction. This is the first report of a hypersensitivity reaction to the GnRH analogue, goserelin acetate (Zoladex, Zeneca Pharmaceuticals, Wilmington, DE).

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Antineoplastic Agents, Hormonal Drug Hypersensitivity Endometriosis Goserelin Adult Antineoplastic Agents, Hormonal Drug Hypersensitivity Endometriosis Female Goserelin Humans

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

Cited by (1)

References (5)

Cited by (1)

Source provenance

europepmc
last seen: 2026-08-22T06:09:51.966504+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:10:57.821266+00:00
unpaywall
last seen: 2026-08-22T06:23:50.750314+00:00
License: CC0 · commercial use OK